Perceived self-efficacy and life satisfaction after traumatic brain injury.
Keith D Cicerone, Joanne Azulay
https://pubmed.ncbi.nlm.nih.gov/17878767Actively Recruiting
Led by Henry M. Jackson Foundation for the Advancement of Military Medicine · Updated on 2026-01-08
222
Participants Needed
2
Research Sites
87 weeks
Total Duration
H
Henry M. Jackson Foundation for the Advancement of Military Medicine
Lead Sponsor
B
Brooke Army Medical Center
Collaborating Sponsor
Researchers are evaluating the Symptom-Targeted Approach to Rehabilitation for Concussion (STAR-C) in adults with a history of mild traumatic brain injury (mTBI). The study aims to compare the effects of in-person STAR-C, telehealth STAR-C, and no treatment on reducing everyday cognitive complaints. The trial also seeks to understand how patient characteristics affect treatment response and to develop a plan for wider use of STAR-C in clinical settings. Participants are randomly assigned to one of three groups: a four-week no treatment waitlist, in-person cognitive rehabilitation, or telehealth cognitive rehabilitation. Those receiving treatment will have up to nine sessions plus a wrap-up session over several weeks. Therapy focuses on compensatory strategies, personalized goals, and homework practice to help make strategy use a habit. The wrap-up session helps participants plan to maintain their progress. During the study, participants complete questionnaires and assessments at baseline, immediately post-treatment, and at one- and three-month follow-ups. Outcome measures include the Common Concussive Cognitive Complaints (C4) and Goal Attainment Scaling (GAS) to track improvement and maintenance. Researchers will also gather feedback from patients and clinicians to guide future implementation. The total duration of participation varies but includes treatment and follow-up visits over several months.
CONDITIONS
Symptom-Targeted Approach to Rehabilitation for Concussion (STAR-C)
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - 4 weeks
Participants randomized to this group will wait for 4 weeks without treatment while maintaining their current treatments. They will complete questionnaires about their symptoms during this time.
1 visit (in-person or remote) at end of wait period
Duration - Up to 4 weeks (up to nine sessions plus one wrap-up session)
Participants receive individual in-person cognitive rehabilitation treatment with up to three sessions per week focusing on compensatory strategies, personalized targets, and weekly homework assignments. The treatment ends with a wrap-up session to plan maintenance.
Up to 10 visits (in-person)
Duration - Up to 4 weeks (up to nine sessions plus one wrap-up session)
Participants receive individual cognitive rehabilitation treatment via telemedicine with up to three sessions per week focusing on compensatory strategies, personalized targets, and weekly homework assignments. The treatment ends with a wrap-up session to plan maintenance.
Up to 10 visits (remote)
Duration - 3 months
Participants are followed for 3 months after treatment to evaluate maintenance of treatment effects and overall progress.
1 visit at 3 months post treatment
Total: 2 locations
1
Desmond T. Doss Health Clinic
Wahiawa, Hawaii, United States, 96786
Actively Recruiting
2
Brooke Army Medical Center
San Antonio, Texas, United States, 78234
Actively Recruiting
M
Marc Blaylock
K
Kalawena N Kalehuawehe
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Keith D Cicerone, Joanne Azulay
https://pubmed.ncbi.nlm.nih.gov/17878767John D Corrigan, Jennifer Bogner
https://pubmed.ncbi.nlm.nih.gov/18025964Bettina Scheffler, Florian Schimböck, Almut Schöler...
https://pubmed.ncbi.nlm.nih.gov/35968277Molly Gromatsky, Sarah R Sullivan, Emily L Mitchell...
https://pubmed.ncbi.nlm.nih.gov/33422845Bryan J Weiner, Cara C Lewis, Cameo Stanick...
https://pubmed.ncbi.nlm.nih.gov/28851459Tetyana B Kendzerska, Peter M Smith, Romina Brignardello-Petersen...
https://pubmed.ncbi.nlm.nih.gov/24135493M W Johns
https://pubmed.ncbi.nlm.nih.gov/1798888L E Kazis, X S Ren, A Lee...
https://pubmed.ncbi.nlm.nih.gov/10446661C Beard, K J Hsu, L S Rifkin...
https://pubmed.ncbi.nlm.nih.gov/26774513K Kroenke, R L Spitzer, J B Williams
https://pubmed.ncbi.nlm.nih.gov/11556941